HomeDTCFF • OTCMKTS
add
Defence Therapeutics Inc
Previous close
$0.41
Year range
$0.40 - $1.82
Market cap
24.74M CAD
Avg Volume
141.00
P/E ratio
-
Dividend yield
-
Primary exchange
CNSX
Market news
Financials
Income Statement
Revenue
Net income
| (CAD) | Sep 2024info | Y/Y change |
|---|---|---|
Revenue | — | — |
Operating expense | 483.12K | -77.09% |
Net income | -606.86K | 72.38% |
Net profit margin | — | — |
Earnings per share | — | — |
EBITDA | -472.07K | 77.48% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (CAD) | Sep 2024info | Y/Y change |
|---|---|---|
Cash and short-term investments | 131.20K | -90.28% |
Total assets | 424.67K | -73.25% |
Total liabilities | 4.55M | 123.99% |
Total equity | -4.12M | — |
Shares outstanding | 47.09M | — |
Price to book | -4.59 | — |
Return on assets | -267.68% | — |
Return on capital | 58.67% | — |
Cash Flow
Net change in cash
| (CAD) | Sep 2024info | Y/Y change |
|---|---|---|
Net income | -606.86K | 72.38% |
Cash from operations | 87.41K | 106.15% |
Cash from investing | — | — |
Cash from financing | -12.76K | 13.01% |
Net change in cash | 74.65K | 105.17% |
Free cash flow | 198.17K | 128.11% |
About
Founded
2017
Headquarters
Website
